Successful cochlear implant surgery for four-year-old Angelo aids hearing, part of a charitable initiative by Care and Share Foundation.
KOCHI: Four-year-old Angelo, hearing impaired since birth, had been living in complete silence. On Monday, his life changed, ...
HealthDay on MSN
First gene therapy for genetic hearing loss gains FDA approval
Key Takeaways Otarmeni, a gene therapy targeting a specific mutation that causes profound deafness, now has U.S. Food and ...
The FDA has approved Otarmeni, the first gene therapy for a rare form of inherited deafness caused by OTOF gene mutations. Clinical trials showed 80% of treated children regained significant hearing, ...
The All India Institute of Medical Sciences Jammu organized second Temporal Bone Dissection Conference, at AIIMS Vijaypur, ...
The FDA has granted accelerated approval to Otarmeni™ (lunsotogene parvec-cwha), the first gene therapy for pediatric and adult patients with OTOF-related sensorineural hearing loss.
Four-year-old Angelo heard Mammootty for the first time after a successful cochlear implant surgery under the Kaathodu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results